DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc(1)
DNDI-6174 是一种用于治疗内脏利什曼病的临床前候选药物,其靶点为细胞色素 bc(1)
期刊:Science Translational Medicine
影响因子:14.6
doi:10.1126/scitranslmed.adh9902
Braillard, Stéphanie; Keenan, Martine; Breese, Karen J; Heppell, Jacob; Abbott, Michael; Islam, Rafiqul; Shackleford, David M; Katneni, Kasiram; Crighton, Elly; Chen, Gong; Patil, Rahul; Lee, Given; White, Karen L; Carvalho, Sandra; Wall, Richard J; Chemi, Giulia; Zuccotto, Fabio; González, Silvia; Marco, Maria; Deakyne, Julianna; Standing, David; Brunori, Gino; Lyon, Jonathan J; Castañeda-Casado, Pablo; Camino, Isabel; Martinez Martinez, Maria S; Zulfiqar, Bilal; Avery, Vicky M; Feijens, Pim-Bart; Van Pelt, Natascha; Matheeussen, An; Hendrickx, Sarah; Maes, Louis; Caljon, Guy; Yardley, Vanessa; Wyllie, Susan; Charman, Susan A; Chatelain, Eric